Article
SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V.
Clinical genetics - 1 Mar 2013
Sánchez-Ferrero E, Coto E, Beetz C, Gámez J, Corao A I, Díaz M, Esteban J, del Castillo E, Moris G, Infante J, Menéndez M, Pascual-Pascual S I, López de Munaín A, Garcia-Barcina M J, Alvarez V
Abstract excerpt
Mutations in the SPG7 gene were initially reported in patients with autosomal recessive hereditary spastic paraplegia (HSP). Recent works suggested a dominant effect for some SPG7 mutations. To characterize the SPG7 mutational spectrum in a large cohort of Spanish HSP patients, we sequenced the whole SPG7 gene in a total of 285 Spastic Paraplegia patients. Large gene rearrangements were also ascertained in some...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
